Jefferies Group LLC Red Hill Biopharma Ltd. Call Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$4.55 - $10.36 $295,750 - $673,400
-65,000 Closed
0 $0
Q2 2021

Sep 21, 2023
BUY
$5.98 - $7.51 $388,700 - $488,150
65,000 New
65,000 $447,000
Q2 2021

Aug 20, 2021
SELL
$5.98 - $7.51 $38.5 Million - $48.3 Million
-6,435,000 Reduced 99.0%
65,000 $447,000
Q2 2021

Aug 16, 2021
BUY
$5.98 - $7.51 $38.9 Million - $48.8 Million
6,500,000 New
6,500,000 $447,000

Others Institutions Holding RDHL

# of Institutions
2
Shares Held
40.4K
Call Options Held
0
Put Options Held
0
View Full List

About RedHill Biopharma Ltd.

RDHL Quotes by TradingView
  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $465M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email